Erschienen in:
06.03.2023 | Lessons for the Clinical Nephrologist
Relapse of atypical hemolytic uremic syndrome triggered by COVID-19: a lesson for the clinical nephrologist
verfasst von:
Ryuta Uwatoko, Mayu Shindo, Nobuhiro Hashimoto, Rei Iio, Yoshiyasu Ueda, Yoshitaka Tatematsu, Noritoshi Kato, Shoichi Maruyama, Terumasa Hayashi
Erschienen in:
Journal of Nephrology
|
Ausgabe 5/2023
Einloggen, um Zugang zu erhalten
Excerpt
A 31-year-old Japanese woman was admitted to her neighboring hospital for dark brown urine. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) quantitative antigen test was positive, and she was referred to our hospital. She had never been vaccinated against or infected with SARS-CoV-2. Her medical history was relevant for three episodes of thrombotic microangiopathy (TMA) at ages 3, 8, and 17 years, triggered by common cold, Campylobacter, and Influenza A infections, respectively. Accordingly, she was treated with red blood cell transfusions for the first and second episodes of TMA, and with fresh frozen plasma transfusion and plasma exchange for the last episode. She had no sequelae. Although her father, paternal uncle, and paternal grandmother had a history of TMA, genetic tests had never been performed. …
